These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2467781)

  • 1. Implementation of a multicomponent process to obtain informed consent in the Diabetes Control and Complications Trial. The DCCT Research Group.
    Control Clin Trials; 1989 Mar; 10(1):83-96. PubMed ID: 2467781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of two formats of informed consent on knowledge amongst persons with advanced HIV disease in a clinical trial of didanosine.
    Tindall B; Forde S; Ross MW; Goldstein D; Barker S; Cooper DA
    Patient Educ Couns; 1994 Dec; 24(3):261-6. PubMed ID: 7753719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of cohort-specific consent and patient control in phase I cancer trials.
    Daugherty CK; Ratain MJ; Minami H; Banik DM; Vogelzang NJ; Stadler WM; Siegler M
    J Clin Oncol; 1998 Jul; 16(7):2305-12. PubMed ID: 9667244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Audio-visual presentation of information for informed consent for participation in clinical trials.
    Ryan RE; Prictor MJ; McLaughlin KJ; Hill SJ
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003717. PubMed ID: 18254029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective.
    Daugherty CK
    J Clin Oncol; 1999 May; 17(5):1601-17. PubMed ID: 10334550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of treatment protocols in the Diabetes Control and Complications Trial.
    Diabetes Care; 1995 Mar; 18(3):361-76. PubMed ID: 7555480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' reasoning regarding the decision to participate in clinical cancer trials: an interview study.
    Dellson P; Nilsson K; Jernström H; Carlsson C
    Trials; 2018 Sep; 19(1):528. PubMed ID: 30268150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is this thing called "randomise"?
    Mason S; Brown J; Levene M
    Lancet; 1997 Nov; 350(9089):1416. PubMed ID: 9371163
    [No Abstract]   [Full Text] [Related]  

  • 10. The diabetes control and complications trial (DCCT): the trial coordinator perspective. Report by the DCCT Research Group.
    Ahern JA; Kruger DF; Gatcomb PM; Petit WA; Tamborlane WV
    Diabetes Educ; 1989; 15(3):236-41. PubMed ID: 2653757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informed consent in psychiatric research: preliminary findings from an ongoing investigation.
    Benson PR; Roth LH; Winslade WJ
    Soc Sci Med; 1985; 20(12):1331-41. PubMed ID: 2862705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes Control and Complications Trial (DCCT). Update. DCCT Research Group.
    Diabetes Care; 1990 Apr; 13(4):427-33. PubMed ID: 2180661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.
    Stryker JE; Wray RJ; Emmons KM; Winer E; Demetri G
    Patient Educ Couns; 2006 Oct; 63(1-2):104-9. PubMed ID: 16242898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). The DCCT Research Group.
    Diabetes Care; 1988 Oct; 11(9):725-32. PubMed ID: 3066604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial.
    Featherstone K; Donovan JL
    BMJ; 1998 Oct; 317(7167):1177-80. PubMed ID: 9794849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of the study coordinator role: the 28-year experience in Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC).
    Larkin ME; Lorenzi GM; Bayless M; Cleary PA; Barnie A; Golden E; Hitt S; Genuth S
    Clin Trials; 2012 Aug; 9(4):418-25. PubMed ID: 22729476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of decision aids for people considering taking part in a clinical trial: a conceptual framework.
    Gillies K; Campbell MK
    Trials; 2019 Jul; 20(1):401. PubMed ID: 31277693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing an alternate informed consent process.
    Yates BC; Dodendorf D; Lane J; LaFramboise L; Pozehl B; Duncan K; Knodel K
    Nurs Res; 2009; 58(2):135-9. PubMed ID: 19289935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How informed is informed consent? The BHAT experience.
    Howard JM; DeMets D
    Control Clin Trials; 1981 Dec; 2(4):287-303. PubMed ID: 6120794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.